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Background: Lifestyle intervention in type 2 diabetes mellitus (T2DM) is effective but needs a special local setting
and is costly. Therefore, in a randomized-controlled trial we tested the hypothesis that the autonomous use of the
interactive exercise game Wii Fit Plus over a period of 12 weeks improves metabolic control, with HbA1c reduction
as the primary outcome, and weight loss, reduction of cardiometabolic risk factors, physical activity and quality of
life (secondary outcomes) in T2DM patients.
Methods: Participants (n = 220) were randomized into an intervention and a control group. The intervention group
was provided with a Wii console, a balance board and the exercise game Wii Fit Plus for 12 weeks. The control
group remained under routine care and received the items 12 weeks later. At baseline and after 12 weeks (and for
the control group additionally after 12 weeks of intervention) the participants’ health parameters, medication,
physical activity and validated questionnaires for quality of life (PAID, SF12, WHO-5, CES-D) were requested and
compared in a complete case analysis using the Mann–Whitney test and the Wilcoxon signed rank test.
Results: 80% of participants completed the 12-week study. Patients in the intervention group significantly improved
HbA1c (from 7.1 ± 1.3% to 6.8 ± 0.9%; -0.3 ± 1.1%; p = 0.0002) in comparison to the control group (from 6.8 ± 0.9% to
6.7 ± 0.7%; -0.1 ± 0.5%) and also significantly reduced fasting blood glucose (from 135.8 ± 38.9 mg/dl to 126.6 ±
36.6 mg/dl; p = 0.04), weight (from 97.6 ± 19.2 kg to 96.3 ± 18.7 kg; p < 0.001) and body mass index (from 34.1 ±
6.5 kg/m2 to 33.5 ± 6.5 kg/m2; p < 0.001). Daily physical activity increased significantly (p < 0.001). Diabetes-dependent
impairment, mental health, subjective wellbeing and quality of life also improved significantly, and the number of
patients with depression decreased. Similar improvements were seen in the control group after exercise game
intervention.
Conclusions: In this trial a low-threshold intervention with the interactive exercise game Wii Fit Plus was able to
motivate T2DM patients to improve physical activity, glucometabolic control and quality of life.
Trial registration: ClinicalTrials.gov NCT01735643.
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Type 2 diabetes mellitus (T2DM) can be successfully
treated by lifestyle change [1]. However, comprehensive
lifestyle interventions need local settings and are cost
intensive. Instead of early and increasing anti-diabetic
medication, motivational, low-threshold interventions
are needed. Interactive exercise games (exergames) are a
new and alternative tool to promote physical activity.
They can be interfaced with a television set and offer
different games (e.g. table tennis, bowling) in order to
substitute sedentary leisure time with active time. There
are some reports addressing health benefits of exercise
gaming [2], however, data are lacking for clinical end-
points of diseases (i.e. HbA1c) or possible effects for
quality of life. Elderly T2DM patients are particularly in-
teresting candidates for exercise games because of their
usually sedentary lifestyle [3]. Therefore, in a randomized-
controlled trial we investigated the hypothesis that au-
tonomous use of the interactive exercise game Wii Fit
Plus over a period of 12 weeks is able to improve HbA1c
(primary outcome) as well as weight, cardiometabolic
risk factors, physical activity and quality of life (secondary
outcomes) in T2DM patients.
Methods
Study subjects
T2DM patients were recruited throughout Germany
via attending physicians or newspaper articles. Eligible
patients (inclusion criteria: diabetes duration <5 years,
aged 50–75 years, BMI ≥ 27 kg/m2, subscribed in the
disease management program (DMP) T2DM; exclusion
criteria: regular physical activity, pharmacological diabetes
therapy with the exception of Metformin or DPP-4
inhibitors) were randomized according to an electronic-
ally generated randomization list (created by trial statisti-
cian) into parallel groups (assigned by study nurse). In
detail, each participant was assigned a serial study ID. For
each ID there was a closed envelope with the group as-
signment. Both the participants and the study nurse were
blinded for sequence of allocation concealment. The inter-
vention group was provided with a Wii console, a balance
board and the exercise game Wii Fit Plus (Nintendo of
Europe GmbH, Frankfurt am Main, Germany) with the in-
struction to use these items for at least 30 min/day during
the next 12 weeks. The control group remained under
routine care (i.e. quarterly visits to the attending physician
according to the DMP T2DM with check of HbA1c,
weight, BMI, blood pressure, and blood lipids and therapy
adjustment if necessary) and received the intervention
12 weeks later. At baseline and after intervention (and for
a secondary analysis additionally for the control group:
after 12 weeks of waiting phase) health parameters (i.e.
weight, BMI, and blood pressure) were measured by the
attending DMP physician. Body weight was measured inlight clothing to the closest 0.1 kg, and height to the
closest 0.5 cm. Blood pressure was measured after a five-
minute rest in a sitting position on both arms. Venous
blood was collected after an overnight fast of 8 h by insert-
ing an intravenous cannula into the forearm vein, and
laboratory parameters (i.e. HbA1c, levels of fasting blood
glucose (FBG), triglycerides, total-, HDL- and LDL choles-
terol) were analyzed at local laboratories. Self-reported
physical activity was assessed according to a 6-point ques-
tionnaire asking for intensity of physical activity during
working and leisure time, frequency of physical activity in
summer and winter, duration of walking and bicycling
time per day during the last 12 weeks. Single values were
summed up with the maximum reachable value set to
100%. Participants in both groups filled out validated
self-assessment questionnaires for diabetes-dependent
impairment (Problem Areas in Diabetes (PAID) [4],
physical and mental health (SF-12) [5]. subjective well-
being (WHO-5) [6], and quality of life (German version
ADS-L (Allgemeine Depressionsskala) of the general
depression scale CES-D [7]). Depression was defined to
be present at a score >39% (PAID), ≤52% (WHO-5) and
≥40 (ADS-L). Primary endpoint was the within-group
difference of HbA1c after 12 weeks of intervention com-
pared between the exercise game intervention group and
the waiting control group; secondary endpoints were dif-
ferences in weight, cardiometabolic risk factors, physical
activity and quality of life measurements. Results from the
waiting controls after their 12 weeks of exercise game
intervention were analyzed separately in a secondary ana-
lysis. The first participant was enrolled on 14.01.2011; the
last subject finished the intervention on 18.09.2012. The
research protocol was approved by the ethics committee
of the Ärztekammer Nordrhein, carried out in Düsseldorf
in accordance with the Declaration of Helsinki and all
participants gave written informed consent.
Statistical analysis
Sample size had been determined by Simple-Interactive-
Statistical-Analysis (http://www.quantitativeskills.com/sisa/
calculations/samsize.htm) assuming that T2DM patients
can improve their HbA1c by using the exercise game
Wii Fit Plus. Our own data indicated that by motivation
for lifestyle change a reduction of 0.7% ± 1.2% of HbA1c
could be achieved [8], while for the control group a reduc-
tion of only 0.2% was assumed. To be able to measure
such a reduction with a power of 90% and a level of sig-
nificance of 5%, at least 206 datasets would be needed.
Since a dropout rate of about 5-10% was estimated, the
plan was to recruit a total of 220 subjects. Complete case
analyses were performed. Missing values from completers
concerning secondary outcomes were substituted by the
‘last-observation-carried-forward’ principle. The Mann–
Whitney test and linear regression analysis with adjustment
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used to analyze differences between groups, Bonferroni's
Multiple Comparison Test for analyses of repeated mea-
surements within groups and the Wilcoxon signed rank
test to determine if differences deviated from 0. Fisher’s
exact test was used to analyse differences between
groups or time points. The level of significance was
0.05. The Bonferroni correction was used for multiple
testing (n = 15) resulting in p = 0.05/15 = 0.033. Statis-
tical analyses were performed using GraphPad Prism
4.03 (GraphPad Software, San Diego, CA, USA) and




220 T2DM patients were randomly assigned to the
intervention (n = 120) and the control group (n = 100;
Figure 1). Baseline parameters were not significantly
different (Table 1). 93 (77.5%) participants of the inter-
vention group completed the study. In the control
group 83 (83.0%) finished the waiting phase and 54
(54.0%) the 12-week intervention. The dropout rate didFigure 1 Flowchart of study participants.not differ significantly between both groups. The drop
outs did not significantly differ from completers con-
cerning their baseline characteristics (Table 2).
Changes in HbA1c
The complete case analysis demonstrated that, during
the 12 weeks of intervention, patients in the interven-
tion group (n = 93) were able to significantly reduce
their HbA1c from 7.1 ± 1.3% to 6.8 ± 1.0%; p = 0.0002;
Figure 2A) while no significant reduction (from 6.8 ± 0.9%
to 6.7 ± 0.7%) was seen in the control group (n = 83) dur-
ing the waiting phase. In detail, the reduction in HbA1c
differed significantly from zero in the intervention group
only (−0.3 ± 1.1%; Figure 2B), but not in the control group
(−0.1 ± 0.5%). HbA1c values were not significantly differ-
ent between groups at baseline or after the 12 week study
period. Nevertheless, the within group differences reached
statistical significance (p = 0.01), and these differences
remained statistically significant after adjustment for base-
line HbA1c and further potential confounders (Table 3).
Even after adjustment for weight reduction, which might
be considered as a mediator for HbA1c improvement, the
effect remained significant. The percentage of participants
Table 1 Baseline characteristics and study effects
Parameters Intervention group (n = 120) Control group (n = 100)
Sex (male/female) [n] 55 (46%) / 65 (54%) 46 (46%) / 54 (54%)
Age [years] 62 ± 11 60 ± 9
Baseline (n = 120) End (n = 93) Δ p Baseline (n = 100) End (n = 83) Δ p
Weight [kg] 98 ± 19 96 ± 19 −1.2 ± 4.7 0.0001 96 ± 22 96 ± 24 −0.7 ± 2.6 0.014
Body mass index [kg/m2] 34.1 ± 6.5 33.5 ± 6.5 −0.4 ± 1.6 0.0001 33.2 ± 6.3 33.2 ± 6.5 −0.3 ± 0.9 0.007
Systolic blood pressure [mmHg] 134 ± 15 132 ± 13 −2 ± 15 ns 135 ± 17 136 ± 17 2 ± 14 ns
Diastolic blood pressure [mmHg] 80 ± 8 79 ± 8 −0.6 ± 10 ns 80 ± 9 80 ± 8 −0,3 ± 9 ns
Fasting blood glucose [mg/dl] 136 ± 39 127 ± 37 −8 ± 35 0.041 130 ± 39 130 ± 37 −3 ± 24 ns
Total cholesterol [mg/dl] 207 ± 43 204 ± 44 −3 ± 23 ns 202 ± 45 201 ± 45 −2 ± 18 ns
HDL cholesterol [mg/dl] 50 ± 14 51 ± 14 0 ± 7 ns 48 ± 11 49 ± 12 0 ± 5 ns
LDL cholesterol [mg/dl] 125 ± 35 125 ± 36 0 ± 23 ns 124 ± 50 120 ± 42 4 ± 26 ns
Triglycerides [mg/dl] 200 ± 123 198 ± 114 2 ± 65 ns 234 ± 251 238 ± 27 5 ± 69 ns
Physical activity [%] 42 ± 19 59 ± 17 12 ± 12 <0.0001 43 ± 21 46 ± 19 4 ± 10 0.002
Treatment with Metformin [%] 73 72 −1 ns 78 81 3 ns
Treatment with DPP-4 inhibitors [%] 16 16 0 ns 19 19 0 ns
HDL, high-density lipoprotein; LDL, low-density lipoprotein. Shown are means ± standard deviations. Self-reported physical activity was estimated according to a
6-point questionnaire asking for intensity of working time physical activity, intensity of leisure time physical activity, frequency of physical activity during winter
time, frequency of physical activity during summer time, duration of walking time per day and duration of bicycling time per day. Single values were summed up
with the maximal reachable value set to 100%. Differences between groups had been determined by Chi-square test and Mann Whitney test.
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in the intervention group from 56 to 65% (+9%) and de-
creased in the control group from 68 to 67% (−1%). When
the control group finished the waiting phase and also
started intervention, a significant reduction of −0.2 ± 0.5%
of HbA1c (p = 0.003) was observed in a secondary ana-
lysis, leading to 78% reaching the treatment goal. WhenTable 2 Baseline characteristics of completers and dropouts
Parameters Intervention group (n
Completers (n = 93) Dr
Sex (male/female) [n] 42 / 51 (45% / 55%) 13
Age [years] 61 ± 7
Weight [kg] 97 ± 19
Body mass index [kg/m2] 33.9 ± 6.4
Systolic blood pressure [mmHg] 134 ± 15
Diastolic blood pressure [mmHg] 79 ± 8
Fasting blood glucose [mg/dl] 134 ± 38
Total cholesterol [mg/dl] 207 ± 42
HDL cholesterol [mg/dl] 50 ± 14
LDL cholesterol [mg/dl] 125 ± 34
Triglycerides [mg/dl] 209 ± 128
Physical activity [%] 42 ± 18
Treatment with Metformin [%] 77
Treatment with DPP-4 inhibitors [%] 14
For details please see legend to Table 1.an intention-to-treat analysis was performed results stayed
the same with a significant reduction of HbA1c of −0.24 ±
0.96% (from 7.1 ± 1.3% to 6.9 ± 1.1%; p = 0.0002) in the
intervention group vs. -0.08 ± 0.47% in the control group
(from 6.8 ± 0.9% to 6.8 ± 0.8%). For the type of interven-
tion (exercise gaming vs. waiting) an independent impact
(p = 0.005) on HbA1c reduction was observed even after= 120) Control group (n = 100)
opouts (n = 27) Completers (n = 83) Dropouts (n = 17)
/ 14 (48% / 52%) 35 / 48 (42% / 58%) 11 / 6 (65% / 35%)
61 ± 9 60 ± 8 63 ± 7
98 ± 21 97 ± 23 92 ± 13
34.4 ± 7.1 33.5 ± 6.5 31.7 ± 4.6
135 ± 13 134 ± 17 138 ± 17
81 ± 9 80 ± 10 80 ± 5
141 ± 41 133 ± 40 118 ± 26
207 ± 45 203 ± 47 198 ± 38
49 ± 8 48 ± 11 46 ± 9
128 ± 31 124 ± 48 123 ± 37
179 ± 84 243 ± 257 188 ± 70
40 ± 23 41 ± 19 52 ± 28
59 78 76
22 19 18
Figure 2 Significant reduction of HbA1c during the 12-week
exercise game intervention. Shown are means ± standard error
of means. (A) HbA1c values have been determined at baseline and
after 12 weeks in the intervention group (n = 93; white bars) and
the control group (n = 83; checked bars) as well as after additional
12 weeks of intervention (n = 54). (B) Differences in HbA1c were
defined as values after 12 weeks of intervention or waiting minus
baseline values, and additionally for the control group, values after
12 weeks of intervention minus values after 12 weeks of waiting.
Differences between groups have been estimated using the
Mann–Whitney test and within groups using the Wilcoxon signed
rank test; Wilcoxon signed rank test was used to determine if
differences were significantly different from 0 (*, p < 0.05;
**, p < 0.01; ***, p < 0.001).
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founders (data not shown). The results even remain robust
after Bonferroni correction for multiple testing.Changes in cardiometabolic risk factors and physical
activity
Significant reduction of weight and BMI was observed in
both groups (Table 1). In the intervention group FBG
levels also improved significantly although the reduction
no longer remained statistically significant after correc-
tion for multiple testing. Patients in the intervention
group reported an increase in physical activity beyond
their activity using the exercise game in everyday life (i.e.
gymnastics, walking, bicycling). Their physical activity
increased more significantly during the 12 weeks of
intervention than those of participants in the control
group, although they were also more physically active
during the waiting phase. When the control group
started the exercise game intervention they also experi-
enced weight reduction by −1.8 ± 3.1 kg of (p < 0.001),
BMI by −0.6 ± 1.0 kg/m2 (p < 0.001), FBG by −7.0 ±
20.4 mg/dl (p = 0.008), and further increased their phys-
ical activity by 10 ± 10% (p < 0.001). Most of participants
did not make use of the exercise game alone but played
together with family members (61% in the intervention
and 63% in the control group, i.e. partners (40% vs. 41%),
children (30% vs. 11%), grandchildren (23% vs. 8%) and
other family members (6% vs. 1%)). Medication levels with
Metformin and DPP-4 inhibitors did not change signifi-
cantly and no adverse or side effects were reported.
Changes in diabetes-dependent impairment, subjective
wellbeing and quality of life
Diabetes-dependent impairment was significantly reduced
in the intervention group compared to the control group
(p = 0.03). In detail, there was a significant reduction of
diabetes-dependent impairment in both groups during
intervention phases, with a reduction of 5.2 ± 13.2% in the
intervention group (p < 0.001) and 4.2 ± 14.7% in the con-
trol group (p = 0.008), while reduction was not statistically
significant during the waiting phase (Figure 3). In addition,
while mental health improved in the intervention group, it
deteriorated in the control group during the 12-week
study (p = 0.02); changes in physical health were not sig-
nificantly different (data not shown). Subjective wellbeing
significantly improved in the intervention group compared
to the control group (p < 0.001). Wellbeing increased sig-
nificantly during the 12-week intervention by 8.6 ± 19.4%
(p < 0.001) in the intervention group and 8.1 ± 21.3% in
the control group (p = 0.004), but did not change signifi-
cantly during the waiting phase. Finally, quality of life in-
creased significantly in the intervention group by 2.4 ±
12.9% (p = 0.03) compared to the control group, which
showed a slight decrease during waiting phase (p = 0.05).
Changes in depression
Depression was measured using the validated question-
naires PAID, WHO-5 and ADS-L. With all instruments,
Table 3 Effect on HbA1c reduction
Unadjusted model Adjusted model 1 Adjusted model 2 Adjusted model 3
Effect size (SEM) p Effect size (SEM) p Effect size (SEM) p Effect size (SEM) p
Intervention −0.332 (0.110) 0.010 −0.229 (0.091) 0.012 −0.228 (0.092) 0.014 −0.211 (0.089) 0.018
Baseline HbA1c - - −0.396 (0.043) <0.0001 −0.397 (0.046) <0.0001 −0.384 (0.044) <0.0001
Age - - - - −0.001 (0.001) 0.885 −0.003 (0.006) 0.665
Sex - - - - 0.025 (0.092) 0.790 0.009 (0.089) 0.924
Weight difference - - - - - - 0.042 (0.011) 0.0003
n = 93 + 83 = 176; Model 1: adjusted to baseline HbA1c; Model 2: adjusted to baseline HbA1c, age and sex; Model 3: adjusted to baseline HbA1c, age, sex and
weight difference.
Figure 3 Improvement in diabetes-dependent impairment, subjective wellbeing and quality of life during exercise game intervention.
Using validated questionnaires we estimated (A) diabetes-dependent impairment (PAID), (B) mental health (SF-12), (C) subjective wellbeing
(WHO-5) and (D) quality of life (ADS-L). For details see legend to Figure 1.
Kempf and Martin BMC Endocrine Disorders 2013, 13:57 Page 6 of 9
http://www.biomedcentral.com/1472-6823/13/57
Kempf and Martin BMC Endocrine Disorders 2013, 13:57 Page 7 of 9
http://www.biomedcentral.com/1472-6823/13/57the percentage of depressed patients had been comparable
in both groups at baseline (PAID: 25 (21%) in the inter-
vention vs. 18 (18%) in the control group; WHO-5: 37
(31%) vs. 36 (36%); ADS-L: 15 (13%) vs. 17 (17%)), al-
though the percentage of patients diagnosed with de-
pression differed according to the questionnaire used
(Figure 4). All three measurements indicate that the
percentage of depressed patients went down in both
groups during exercise game intervention, although
only depression measurement using the WHO-5 ques-
tionnaire reached a statistical significance (15 (16%) in
the intervention group after intervention (p = 0.019); 30
(36%) vs. 11 (20%) in the control group comparing the
waiting and the intervention phase (p = 0.018)). During
the waiting phase the percentage of depressed patients
remained stable.
Discussion
To our knowledge this is the first randomized-controlled
trial showing a benefit of exergaming for a clinical end-
point and for the quality of life of a disease. In this study
we demonstrate a significant reduction of HbA1c, weight
and BMI during the 12-week intervention. The majority of
participants reported having played together with family
members, and that the extent of their physical activity in-
creased not only during exergaming but also in everyday
life. Significant improvements in diabetes-dependent im-
pairment, subjective wellbeing and quality of life as well as
a reduction of depression were observed. Therefore,Figure 4 Percentage of patients with depression. Depression was self-a
(C) ADS-L. Participants who reached a score >39% (PAID), ≤52% (WHO-5) a
with depression is given by the checked part of the bar, the white part of the
test was used to analyze if the numbers of depressed participants differed beexercise games may potentially be used in a home setting
as a tool to reduce sedentary behavior in T2DM.
It has been known for a long time that lifestyle inter-
vention programs are successful for the treatment of pa-
tients with manifested T2DM. The Look-AHEAD
(Action For Health in Diabetes) study [1,9] demon-
strated that with a combination of a calorie restricted
diet, exercise, motivation and self-monitoring of blood
glucose, patients could achieve a decrease of mean
HbA1c from 7.3 to 6.6%, an 8.6% weight loss, and a sig-
nificant reduction of anti-diabetic medication within one
year. After four years, HbA1c reduction was maintained
at −0.36% and weight loss at −6.2% [9]. Also a recent
meta-analysis of community-based physical activity for
adults with type 2 diabetes revealed a significant lower-
ing of HbA1c levels by −0.32% [95% CI −0.65, 0.01] [10].
However, it needs to be emphasized that such interven-
tions required an enormous amount of personal and
economical effort. In contrast, in our approach, mentor-
ing and costs were low, just mailing the Wii console
with balance board, and the exercise game Wii Fit Plus.
For the point of view of the participants, the use of the
game was a low-threshold proposal for lifestyle interven-
tion. In detail, we did not test the effect of physical activ-
ity on glucometabolic control, but just the effect of
providing a device for interactive exercise in order to en-
courage self-motivation in the participants. Nevertheless,
a comparable HbA1c reduction of 0.3% was reached and
the percentage of participants reaching the HbA1c goalssessed using the validated questionnaires (A) PAID, (B) WHO-5 and
nd ≥40 (ADS-L) were diagnosed as depressed. The percentage of patients
bar gives the percentage of participants without depression. Fisher’s exact
tween groups or points in time (*, p < 0.05).
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ing the efficacy of pharmacological therapies demon-
strated that the amount of HbA1c reduction essentially
depends on baseline HbA1c [12]. HbA1c reduction seems
to be greater the higher the baseline levels had been previ-
ously. With a mean baseline HbA1c of 7.0-7.9%, therapies
with oral antidiabetic medication achieved an HbA1c re-
duction of 0.1%, while in our study the baseline HbA1c in
the intervention group was 7.1 ± 1.3%, and a reduction of
0.3% was achieved.
Data about the use of exercise games for lifestyle
intervention in the elderly are scarce, although a sys-
tematic review revealed significant health benefits in
older adults [13]. For Wii Fit, especially, it has already
been shown that regular use might be a vehicle for in-
creasing physical activity in the elderly [14]. Moreover,
cycling games seem to increase cognition in older adults
[15]. It has also been used for lifestyle intervention in
adolescents to encourage them to lose weight [16].
Overweight school children were encouraged to play an
exercise game for 30-60 min/school day for a period of
20 weeks during lunch-time or after school. Adolescents
played with or against a peer to expend calories, while
in the control group participants played alone. Within
this controlled setting, the highest weight loss with a mean
of 1.7 ± 4.5 kg was achieved with cooperative playing, and
also measurements for self-efficacy increased. This finding
is fully in line with our results, demonstrating that the
majority of participants preferred to play with family
members rather than by themselves. Since key motiva-
tors to physical activity were weight management, feel-
ings of physical and mental well being, as well as social
relationships associated with physical activity, exercise
games should help to motivate players to exercise, and
could take advantage of group dynamics to motivate
players in terms of the duration of the exercise period
[17]. Obviously, the motivating effects are not only
short-term but are maintained and sufficient to signifi-
cantly reduce long-term blood-glucose parameters such
as HbA1c. Another study including adolescents playing
exercise games alone or with a virtually present partner
demonstrated significantly higher persistence in all ex-
perimental conditions with the virtual partner present
[18]. One explanation for this might be the finding that
cooperative exercise gaming produces a higher intrinsic
motivation that comes from a desire for control and
this is related to a higher expenditure of energy [19].
Therefore, exercise games are mostly played in a social
context [20]. This might not be true only for young-
sters, but also for the elderly, since a meta-analysis
reported significant mental health outcomes in the ma-
jority of the reviewed studies, resulting in positive con-
sequences for physical and lastly social health in older
adults [13].Key motivations for playing exercise games were percep-
tions of enjoyment, feeling better afterwards and participa-
tion in a social context [21]. This is fully in line with our
results, which demonstrated that during the 12-week exer-
cise game intervention, diabetes-dependent impairment
decreased, and mental health, subjective wellbeing and
quality of life improved significantly. The combination of
physical activity per se, the feeling of having done some-
thing positive for one’s health, and playing fun games with
family members seems to strengthen patients’ motivation,
resulting not only in weight loss and improvement of
glucometabolic control but also in an positive attitude
towards life.
Our study has several limitations that need to be consid-
ered. First, a completer rate of only 67% was achieved and
of those a completer analysis had been performed. The
patients who managed to improve their glucometabolic
control may have been more strongly motivated to stay
with the program. This might have biased the results and
the effects might have been weakened in the complete
study population. Nevertheless, the percentage of drop out
in our study are comparable to those seen in other exer-
cise interventions for older adults [22] and the fact that
the baseline characteristics of completers and dropouts,
the results of the intention-to-treat analysis as well as the
outcomes in both groups after exercise intervention did
not differ, argues against such a responder bias. Second, it
might be seen as limitation of our study that the exercise
game was used at home in an uncontrolled setting and
that no objective information was obtained about the
duration and intensity of exercising. However, it was our
particular aim to create a situation close to real-life, where
T2DM patients were not enclosed in an expensive and all-
embracing mentoring program but had the opportunity of
performing physical activities on their own in order to
demonstrate the potential of a low-threshold intervention
for clinical outcomes. Therefore, we refrained from close
supervision. Third, data was self-reported and clinical pa-
rameters were not measured in a standardized manner
but at local laboratories. This did not affect the intra-
individual analysis because glucometabolic measurements
were performed at baseline and at end of study in the
same local laboratory and were reported in written form
by the attending physician. In assessing physical activity,
diabetes-dependent impairment, subjective wellbeing and
quality of life, validated self-assessment questionnaires
were used and the comparison baseline vs. end of study
was performed using the same algorithm. It might be
speculated that the patients participating in this study
might have been more strongly motivated than the general
T2DM population. Nevertheless, that might be true for all
patients participating in clinical studies. Perhaps those
patients who had heard about the Wii and exercise games
from their children or grandchildren might have been
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patients who are physically able, exercise games might
offer an alternative form of home exercise.
Conclusions
Our data demonstrated a significant improvement in
glucometabolic control and quality of life during a low-
threshold intervention with the interactive exercise game
Wii Fit Plus. Given the positive attitudes of the partici-
pants and the limited restrictions for gaming at home,
exercise games may potentially be used in a home setting
as a tool to reduce sedentary behavior in T2DM. In future,
exercise games should be specially developed for this
group of patients, glucometabolic control should be opti-
mized and, in order to increase adherence, online transfer
of performed exercises, as well as telediabetological coach-
ing, should be included in a treatment program.
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